COVID-19: What are best practices for informed consent in CTIMPs? How can we help ensure these though Quality Management and Audit?
Webinar - Free Q&A Session
Description
| Event | Webinar |
| Type | Virtual Event |
| Language | English |
| Date(s) | 07 Jun. 2021 |
| Day(s) | 17:00 - 18:00 |
| Duration | 1 hour |
Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.
Programme
| 17:00 |
Opening of the Webinar Moderator(s): Hugh Davies, National Research Ethics Service |
|
The ethical requirements for consent processes: what RECs look for
Heather Sampson, University of Toronto
Hugh Davies, National Research Ethics Service
|
|
|
Quality management and consent: what QA is looking for
Seif Eddine Amara Madi, GSK
|
|
|
Open discussion and comment: “Good consent practice”Open discussion and comment: “Good consent practice” |
|
|
Audit/Inspection and consent : standards, what we do now, what might be critical findings when auditing consent?
Belinda Pearce, BP Quality Solution
|
|
|
Panel and audience discussion : “Matching these up – how can QM and audit help?
Beat Widler, WS QMS
Cathy Dove, Dove Quality Solutions
Louise Mawer, Mirabilitas
Mark Poulton, Poulton Quality Solutions
|
|
| 18:00 |
End of the Webinar |